# BRENZAVVY
> **NDA214373** · New Drug Application · Sponsor: THERACOSBIO · Approved 2023-01-20
## Drug
- **FDA Application Number:** NDA214373
- **Application type:** New Drug Application
- **Brand name:** BRENZAVVY
- **Generic name:** BEXAGLIFLOZIN
- **Active ingredients:** BEXAGLIFLOZIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** THERACOSBIO
- **Manufacturer:** TheracosBio, LLC
- **First approval:** 2023-01-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214373)
---
*MORVS · CC0 1.0*